MAKO Surgical Corp. INVESTOR ALERT: Levi & Korsinsky, LLP

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MAKO Surgical Corp. INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by Board of MAKO Surgical Corp. in Connection With Sale of Company to Stryker Corporation -- MAKO

NEW YORK, Oct. 2, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of MAKO Surgical Corp. ("MAKO Surgical" or the "Company") (Nasdaq: MAKO ) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Stryker Corporation (NYSE: SYK ). A complaint was filed in Florida state court.

Click here to learn more about the case http://zlk.9nl.com/makosurgical/ , or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, MAKO Surgical shareholders will receive $30.00 for each share of MAKO Surgical stock they own. The transaction has a total approximate value of $1.65 billion. The claims concern whether the MAKO Surgical Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Stryker Corporation is underpaying for MAKO Surgical shares.

If you own MAKO Surgical common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/makosurgical/ .

Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 26

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 21

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Crypto Developments: Circle's Blockchain, Ethereum Bets, and More

Updated Category News Views 251

The Current Landscape of Cryptocurrency The last week in the world of cryptocurrency and finance has been nothing less than exhilarating. With significant developments, including the launch of a new blockchain by Circle Internet Group Inc. and major investments in Ethereum, there is plenty to discuss. Let’s explore the most noteworthy stories that are shaping the crypto...

Continue Reading
ezPaycheck 2025 Payroll Software: Cost-Effective Compliance Solution

Updated Category News Views 132

ezPaycheck 2025: The Efficient Payroll Solution The new ezPaycheck 2025 payroll software is now available, offering businesses an excellent in-house solution for payroll processing that is both compliant and economical. This updated version comes with essential features designed to make payroll management easier than ever. Priced at just $169 for a single installation,...

Continue Reading
Investors of Applied Therapeutics, Inc. Should Take Action Now

Updated Category News Views 188

Understanding the Securities Fraud Allegations Against Applied Therapeutics Applied Therapeutics, Inc. (APLT) has found itself at the heart of a securities fraud class action lawsuit. This legal proceeding has been announced by The Law Offices of Frank R. Cruz as they represent investors who acquired shares during a significant time frame. The legal challenge highlights...

Continue Reading
Ardagh Metal Packaging Reports Positive Year-End 2024 Results

Updated Category News Views 148

Ardagh Metal Packaging's Year-End 2024 Results Ardagh Metal Packaging S.A. (NYSE: AMBP) recently reported their impressive results for the full year and fourth quarter of 2024. The company's performance is a reflection of strategic growth and resilience in a challenging market environment. Quarterly and Annual Performance Overview For the fourth quarter of 2024, Ardagh...

Continue Reading
Empowering Voices: The Call to Protect Our Children

Updated Category News Views 243

Making a Stand Against Child Trafficking In a heartfelt initiative, ThinkCareBelieve has announced a powerful call to action aimed at ensuring the safety and protection of children across the nation. This initiative addresses the urgent concern of child trafficking and the plight of missing children, many of whom have been smuggled through borders and placed in unsafe...

Continue Reading